相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus
R. R. Henry et al.
DIABETES OBESITY & METABOLISM (2012)
Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study
C. Beysen et al.
DIABETOLOGIA (2012)
Loss of FXR Protects against Diet-Induced Obesity and Accelerates Liver Carcinogenesis in ob/ob Mice
Yanqiao Zhang et al.
MOLECULAR ENDOCRINOLOGY (2012)
Effect of Colesevelam Hydrochloride on Glycemia and Insulin Sensitivity in Men With the Metabolic Syndrome
Gloria Lena Vega et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene
Jonathan Y. Bass et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading
Thijs W. H. Pols et al.
CELL METABOLISM (2011)
Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
Janne Prawitt et al.
DIABETES (2011)
COLESEVELAM HYDROCHLORIDE ADDED TO BACKGROUND METFORMIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A POOLED ANALYSIS FROM 3 CLINICAL STUDIES
Harold E. Bays
ENDOCRINE PRACTICE (2011)
Dual Farnesoid X Receptor/TGR5 Agonist INT-767 Reduces Liver Injury in the Mdr2-/- (Abcb4-/-) Mouse Cholangiopathy Model by Promoting Biliary HCO3- Output
Anna Baghdasaryan et al.
HEPATOLOGY (2011)
Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
Mitsuhiro Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Farnesoid X receptor represses hepatic human APOA gene expression
Indumathi Chennamsetty et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
Thijs W. H. Pols et al.
JOURNAL OF HEPATOLOGY (2011)
Studies in mice, hamsters, and rats demonstrate that repression of hepatic apoA-I expression by taurocholic acid in mice is not mediated by the farnesoid-X-receptor
Christophe Gardes et al.
JOURNAL OF LIPID RESEARCH (2011)
The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling
Tingting Li et al.
MOLECULAR ENDOCRINOLOGY (2011)
Progress and challenges in translating the biology of atherosclerosis
Peter Libby et al.
NATURE (2011)
Bile Acid Sequestration Reduces Plasma Glucose Levels in db/db Mice by Increasing Its Metabolic Clearance Rate
Maxi Meissner et al.
PLOS ONE (2011)
The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
Sabrina Cipriani et al.
PLOS ONE (2011)
Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1
Quan Shang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
The bile acid sensor FXR regulates insulin transcription and secretion
Barbara Renga et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes
Verena Keitel et al.
BIOLOGICAL CHEMISTRY (2010)
Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists
Ulrich Abel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5
Mark R. Herbert et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
COLESEVELAM HYDROCHLORIDE TO TREAT HYPERCHOLESTEROLEMIA AND IMPROVE GLYCEMIA IN PREDIABETES: A RANDOMIZED, PROSPECTIVE STUDY
Yehuda Handelsman et al.
ENDOCRINE PRACTICE (2010)
The nuclear receptor FXR is expressed in pancreatic β-cells and protects human islets from lipotoxicity
Iuliana Ristea Popescu et al.
FEBS LETTERS (2010)
Bile Salt Sequestration Induces Hepatic De Novo Lipogenesis Through Farnesoid X Receptor- and Liver X Receptorα-Controlled Metabolic Pathways in Mice
Hilde Herrema et al.
HEPATOLOGY (2010)
Improved Glycemic Control with Colesevelam Treatment in Patients with Type 2 Diabetes Is Not Directly Associated with Changes in Bile Acid Metabolism
Gemma Brufau et al.
HEPATOLOGY (2010)
Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia
Yanqiao Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-γ and Interfering with the Wnt/β-Catenin Pathways
Mouaadh Abdelkarim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Colestimide, an anion exchange resin agent, can decrease the number of LDL particles without affecting their size in patients with hyperlipidemia
Noriaki Kishimoto et al.
JOURNAL OF CARDIOLOGY (2010)
Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice
Galya Vassileva et al.
JOURNAL OF ENDOCRINOLOGY (2010)
A fresh look at NASH pathogenesis. Part 1: The metabolic movers
Claire Z. Larter et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
Sabrina Cipriani et al.
JOURNAL OF LIPID RESEARCH (2010)
Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates
Joseph T. Lundquist et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Structure-Activity Relationship Study of Betulinic Acid, A Novel and Selective TGR5 Agonist, and Its Synthetic Derivatives: Potential Impact in Diabetes
Cedric Genet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
Giovanni Rizzo et al.
MOLECULAR PHARMACOLOGY (2010)
The Effect of Colesevelam Hydrochloride on Insulin Sensitivity and Secretion in Patients With Type 2 Diabetes: A Pilot Study
Sherwyn L. Schwartz et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2010)
Cholestyramine Reverses Hyperglycemia and Enhances Glucose-Stimulated Glucagon-Like Peptide 1 Release in Zucker Diabetic Fatty Rats
Lihong Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia
Mark J. Evans et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Chronic stimulation of farnesoid X receptor impairs nitric oxide sensitivity of vascular smooth muscle
Taiki Kida et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Antiatherosclerotic effect of farnesoid X receptor
Andrea Mencarelli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Colesevelam HC1 effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes
Robert S. Rosenson et al.
ATHEROSCLEROSIS (2009)
FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease States
Jongsook Kim Kemper et al.
CELL METABOLISM (2009)
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Charles Thomas et al.
CELL METABOLISM (2009)
The Membrane-Bound Bile Acid Receptor TGR5 Is Localized in the Epithelium of Human Gallbladders
Verena Keitel et al.
HEPATOLOGY (2009)
Treatment of nonalcoholic steatohepatitis with colestimide
Makiko Taniai et al.
HEPATOLOGY RESEARCH (2009)
An Increased Flux through the Glucose 6-Phosphate Pool in Enterocytes Delays Glucose Absorption in Fxr-/- Mice
Theo H. van Dijk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
Songwen Zhang et al.
JOURNAL OF HEPATOLOGY (2009)
Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice
Helen B. Hartman et al.
JOURNAL OF LIPID RESEARCH (2009)
Discovery of 3-Aryl-4-isoxazolecarboxamides as TGR5 Receptor Agonists
Karen A. Evans et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery of 6α-Ethyl-23(S)-methylcholic Acid (S-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity
Roberto Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)
Brenton Flatt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
Bo Kong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Coordinated Regulation of Dimethylarginine Dimethylaminohydrolase-1 and Cationic Amino Acid Transporter-1 by Farnesoid X Receptor in Mouse Liver and Kidney and Its Implication in the Control of Blood Levels of Asymmetric Dimethylarginine
Jiang Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner
Josep Maria Del Bas et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Preliminary report: genetic variation within the GPBAR1 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus
Karsten Muessig et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Philippe Lefebvre et al.
PHYSIOLOGICAL REVIEWS (2009)
Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy
Ronald B. Goldberg et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin - Glucose and lipid effects
Harold E. Bays et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Expression and function of the bile acid receptor TGR5 in Kupffer cells
Verena Keitel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064
Adwoa Akwabi-Ameyaw et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy
Vivian A. Fonseca et al.
DIABETES CARE (2008)
Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes
Cedric Langhi et al.
FEBS LETTERS (2008)
Novel potent and selective bile acid derivatives as TGR5 agonists: Biological screening, structure-activity relationships, and molecular modeling studies
Hiroyuki Sato et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity
Romain Gineste et al.
MOLECULAR ENDOCRINOLOGY (2008)
Dietary procyanidins lower triglyceride levels signaling through the nuclear receptor small heterodimer partner
Josep Maria Del Bas et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Targeting bile-acid signalling for metabolic diseases
Charles Thomas et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation
Stephen M. Soisson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells
Qiuhong Zhang et al.
CARDIOVASCULAR RESEARCH (2008)
FXR-mediated regulation of eNOS expression in vascular endothelial cells
Jiang Li et al.
CARDIOVASCULAR RESEARCH (2008)
Farnesoid X receptor ligands inhibit vascular smooth muscle cell inflammation and migration
Yoyo T. Y. Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Insook Kim et al.
JOURNAL OF LIPID RESEARCH (2007)
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption
Diana Jung et al.
JOURNAL OF LIPID RESEARCH (2007)
Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea
Hiroyuki Sato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors
Marie-Louise Ricketts et al.
MOLECULAR ENDOCRINOLOGY (2007)
Bile acids and lipoprotein metabolism: Effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression
L.-M. Nilsson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia
Tadashi Yamakawa et al.
ENDOCRINE JOURNAL (2007)
Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients
Carmine Savoia et al.
HYPERTENSION (2007)
Results of the Glucose-Lowering Effect of WelChol Study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes
Franklin J. Zieve et al.
CLINICAL THERAPEUTICS (2007)
Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes
Christian Rask-Madsen et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Bile acid sequestrants and the treatment of type 2 diabetes mellitus
Bart Staels et al.
DRUGS (2007)
Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation
Tonghuan Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Effects of FXR in foam-cell formation and atherosclerosis development
Grace L. Guo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice
Yanqiao Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo
Giovanni Rizzo et al.
MOLECULAR PHARMACOLOGY (2006)
Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice
Takaharu Maruyama et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK
Behzad Molavi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Back door modulation of the farnesoid X receptor: Design, synthesis, and biological evaluation of a series of side chain modified chenodeoxycholic acid derivatives
Roberto Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Effects of chenodeoxycholic acid and deoxycholic acid on cholesterol absorption and metabolism in humans
Yanwen Wang et al.
TRANSLATIONAL RESEARCH (2006)
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
B Cariou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters
S Bilz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Colesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemia
RS Rosenson
ATHEROSCLEROSIS (2006)
Farnesoid X receptor is essential for normal glucose homeostasis
K Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
T Inagaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: A scientific review
William Insull
SOUTHERN MEDICAL JOURNAL (2006)
Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells
FT He et al.
CIRCULATION RESEARCH (2006)
Bile salt biotransformations by human intestinal bacteria
JM Ridlon et al.
JOURNAL OF LIPID RESEARCH (2006)
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
M Watanabe et al.
NATURE (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice
EA Hanniman et al.
JOURNAL OF LIPID RESEARCH (2005)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition
D Duran-Sandoval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis
S Fiorucci et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1
S Katsuma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Regulation of carbohydrate metabolism by the farnesoid X receptor
KR Stayrook et al.
ENDOCRINOLOGY (2005)
The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand
TP Burris et al.
MOLECULAR PHARMACOLOGY (2005)
Glucose regulates the expression of the farnesoid X receptor in liver
D Duran-Sandoval et al.
DIABETES (2004)
Expression and activation of the farnesoid X receptor in the vasculature
D Bishop-Bailey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
JYL Chiang
JOURNAL OF HEPATOLOGY (2004)
Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein Al gene transcription
P Delerive et al.
MOLECULAR ENDOCRINOLOGY (2004)
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model
A Moschetta et al.
NATURE MEDICINE (2004)
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis
S Fiorucci et al.
GASTROENTEROLOGY (2004)
Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4
H Hirokane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1
K Yamagata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The farnesoid X receptor induces very low density lipoprotein receptor gene expression
A Sirvent et al.
FEBS LETTERS (2004)
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
M Watanabe et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle
E De Fabiani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse
DQH Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Guggulipid for the treatment of hypercholesterolemia - A randomized controlled trial
PO Szapary et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
T Claudel et al.
GASTROENTEROLOGY (2003)
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis
JA Holt et al.
GENES & DEVELOPMENT (2003)
Structural basis for bile acid binding and activation of the nuclear receptor FXR
LZ Mi et al.
MOLECULAR CELL (2003)
A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR
M Downes et al.
MOLECULAR CELL (2003)
Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump
J Cui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A G protein-coupled receptor responsive to bile acids
Y Kawamata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of gene-selective modulators of the bile acid receptor FXR
I Dussault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
G Lambert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries
KC Nicolaou et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2003)
Identification of membrane-type receptor for bile acids (M-BAR)
T Maruyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Bile acids enhance low density lipoprotein receptor gene expression via a MAPK cascade-mediated stabilization of mRNA
M Nakahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The small heterodimer partner interacts with the liver X receptor α and represses its transcriptional activity
C Brendel et al.
MOLECULAR ENDOCRINOLOGY (2002)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor
J Wu et al.
MOLECULAR ENDOCRINOLOGY (2002)
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
CR Pullingr et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
A natural product that lowers cholesterol as an antagonist ligand for FXR
NL Urizar et al.
SCIENCE (2002)
Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters
RM Huber et al.
GENE (2002)
Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids
HR Kast et al.
MOLECULAR ENDOCRINOLOGY (2001)
The negative effects of bile acids and tumor necrosis factor-α on the transcription of cholesterol 7α-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4 -: A novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors
E De Fabiani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
W Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression
NL Urizar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
B Goodwin et al.
MOLECULAR CELL (2000)
Identification of a chemical tool for the orphan nuclear receptor FXR
PR Maloney et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
